Evidence map›Paper›PMID 31192006›Full record

ArticleCardiology research and practice2019

Primary Mechanism Study of

Xin Zhou, Zhi-Cheng Li, Pei-Pei Chen, Rui-Fang Xie

Abstract read
In one paragraph

Article in Cardiology research and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Efficacy and safety ofFrontiers in pharmacology · 2024
    Pooled it
  2. Review
  3. Article
  4. Frontiers in pharmacology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. BioMed research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin ZhouLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID 0000-0003-2454-0784
Zhi-Cheng LiShanghai Pu Dong Hospital, Fu Dan University, Shanghai 200433, China.
Pei-Pei ChenLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Rui-Fang XieLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectiveTo investigate effects of

methodsThe proximal left anterior descending coronary artery in rats was ligated to induce acute myocardial infarction. Then, animals were randomly assigned to four experimental groups: MI control group, Betaloc control group (with Betaloc 10 mg/kg/d), FD500 (low-dose) group (

resultsTwo weeks after MI, PN-F significantly enhanced capillary density in the border area of MI, decreased infarct size, improved minimal vessels, suppressed cell apoptosis, and enhanced expressions of genes (HIF-1, VEGFA, and KDR) and proteins (Bcl-2 and Bax).

conclusionsPN-F demonstrated a potential herb to treat rats with myocardial infarction through promoting angiogenesis and inhibition of apoptosis in the infarct area.

Identifiers

PMID31192006
PMCPMC6525894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.